GVB Biopharma Email Format
Biotechnology ResearchNevada, United States51-200 Employees
GVB Biopharma is a biotechnology company focused on hemp and cannabinoid research that operates along the full value chain. It maintains vertical integration from cultivation through extraction and testing to formulation, supporting both raw materials and finished products. The company runs two facilities: a 30,000-square-foot hemp processing plant in Central Oregon and a 40,000-square-foot white-label product manufacturing site in Las Vegas, providing materials and contract manufacturing. Its services include sustainable hemp farming, extraction, in-house testing, wholesale raw materials, custom formulations, and private-label production. Based in Las Vegas, Nevada, the company serves brands and manufacturers seeking hemp-derived ingredients, formulation development, and private-label production. In March 2025 it launched CBT Isolate, reflecting ongoing product expansion, and it has previously expanded its European footprint with a distribution facility in the Netherlands.